Rhumbline Advisers Increases Position in DocGo Inc. (NASDAQ:DCGO)

Rhumbline Advisers lifted its position in shares of DocGo Inc. (NASDAQ:DCGO) by 4.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 142,762 shares of the company’s stock after purchasing an additional 6,204 shares during the period. Rhumbline Advisers owned about 0.14% of DocGo worth $605,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of DCGO. Centiva Capital LP purchased a new stake in DocGo during the 3rd quarter worth about $43,000. Intech Investment Management LLC acquired a new stake in shares of DocGo during the 3rd quarter worth about $62,000. Victory Capital Management Inc. lifted its stake in DocGo by 100.3% during the third quarter. Victory Capital Management Inc. now owns 51,349 shares of the company’s stock worth $170,000 after purchasing an additional 25,714 shares during the last quarter. SG Americas Securities LLC boosted its holdings in DocGo by 12.9% in the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after purchasing an additional 4,905 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in DocGo by 151.1% in the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock valued at $365,000 after purchasing an additional 66,097 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Price Performance

Shares of DocGo stock opened at $3.03 on Friday. The firm’s fifty day simple moving average is $4.48 and its 200-day simple moving average is $4.00. DocGo Inc. has a 12 month low of $2.75 and a 12 month high of $5.68. The stock has a market capitalization of $309.21 million, a price-to-earnings ratio of 10.82, a PEG ratio of 14.16 and a beta of 1.08.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus reduced their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Finally, Needham & Company LLC dropped their price objective on DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $4.89.

Insiders Place Their Bets

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares in the company, valued at approximately $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.70% of the stock is currently owned by insiders.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.